The Journal of Immunology, Vol 154, Issue 8 4174-4186, Copyright © 1995 by American Association of Immunologists

ARTICLES

CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef

F Hadida, G Haas, N Zimmermann, A Hosmalin, R Spohn, A Samri, G Jung, P Debre and B Autran
Laboratory for Cellular and Tissue Immunology, University Hospital Center Pitie-Salpetriere, Paris, France.

In a previous analysis of HIV-1-specific CTLs in lymphoid organs from HIV-seropositive patients, we reported high frequencies of in vivo differentiated CTLs directed against two immunodominant regions in the central and in the C-terminal part of the HIV-1 Nef protein. The present study analyzes the epitopes recognized by CTLs in the carboxyl terminus of Nef (amino acids 182-205). In addition to several epitopes that are recognized in association with different HLA molecules (A1, A2, A25(10), B35, B52), we defined an optimal nonapeptide (190-198). This nonapeptide was recognized by CTLs down to nanomolar concentrations in the context of at least two HLA molecules, HLA-B52 and HLA-A2, including three HLA-A2 subtypes: HLA-A2.1, -A2.2, and - A2.4. We also determined the relative frequencies of effector CTLs directed against peptide 190-198 to be as high as 10(-4), as opposed to lower frequencies ranging between 5 x 10(-5) and 5 x 10(-6) observed for the other peptides recognized in the same region, thus confirming the optimal presentation of this nonapeptide in vivo. Molecular modeling of the interactions between HLA-A2.1 and Nef peptide 190-198 suggests the formation of a stable complex and allowed us to study sequence motifs that are important for the binding of the HIV-1 peptide in the pockets of the HLA-A2.1 molecule.

This article has been cited by other articles:

				V. Sanchez-Merino, S. Nie, and K. Luzuriaga HIV-1-Specific CD8+ T Cell Responses and Viral Evolution in Women and Infants J. Immunol., November 15, 2005; 175(10): 6976 - 6986. [Abstract] [Full Text] [PDF]

				H. Toh, N. Kamikawaji, T. Tana, S. Muta, T. Sasazuki, and S. Kuhara Magnitude of structural changes of the T-cell receptor binding regions determine the strength of T-cell antagonism: molecular dynamics simulations of HLA-DR4 (DRB1*0405) complexed with analogue peptide Protein Eng. Des. Sel., June 1, 2000; 13(6): 423 - 429. [Abstract] [Full Text] [PDF]

				C. C. Wilson, W. C. Olson, T. Tuting, C. R. Rinaldo, M. T. Lotze, and W. J. Storkus HIV-1-Specific CTL Responses Primed In Vitro by Blood-Derived Dendritic Cells and Th1-Biasing Cytokines J. Immunol., March 1, 1999; 162(5): 3070 - 3078. [Abstract] [Full Text] [PDF]

				S. S. Balla-Jhagjhoorsingh, G. Koopman, P. Mooij, T. G. M. Haaksma, V. J. P. Teeuwsen, R. E. Bontrop, and J. L. Heeney Conserved CTL Epitopes Shared Between HIV-Infected Human Long-Term Survivors and Chimpanzees J. Immunol., February 15, 1999; 162(4): 2308 - 2314. [Abstract] [Full Text] [PDF]

				F. Hadida, V. Vieillard, B. Autran, I. Clark-Lewis, M. Baggiolini, and P. Debre HIV-specific T Cell Cytotoxicity Mediated by RANTES Via the Chemokine Receptor CCR3 J. Exp. Med., August 3, 1998; 188(3): 609 - 614. [Abstract] [Full Text] [PDF]